Skip to content

asbestosiscancer.center

Menu
  • asbestosiscancer news
  • Treatment
  • Asbestosis Treatmeant
  • Tipes of Cancer
  • About us
    • Terms and Conditions
    • DMCA
    • Contact
    • Privacy Policy
    • DMCA
Menu

First Patient Dosed With Experimental Cancer-Killing Virus in New Trial – Gizmodo

Posted on May 19, 2022 by Asbestosis Cancer Center

Advertisement
Scientists dosed the first patient this week in a small clinical trial of an experimental cancer treatment—one that relies on a novel kind of ally. The treatment uses a virus engineered to selectively kill cancer cells, while also amplifying the body’s immune response to the cancer. The hope is that this therapy can help those with advanced solid tumor cancers, in combination with other existing drugs.
The CF33-hNIS virus, also called Vaxinia, was originally created by researchers at the City of Hope National Medical Center in California. It’s now being jointly developed with the company Imugene Limited.
Vaxinia is billed as an oncolytic virus, meaning it prefers to target and infect tumor cells. Scientists have been hopeful about using these kinds of viruses to directly kill off cancer cells for more than a century, but with limited success so far. In recent years, some teams have decided to explore a slightly different plan of attack. This genetically modified virus not only infects and harms cancer cells, but also forces these cells to become more recognizable to the immune system.
This strategy, the researchers hope, will then allow other treatments that also boost our immune response to cancer cells to be more effective, particularly against hard-to-target solid tumors. These treatments are collectively known as immunotherapy. In early animal and lab experiments, the virus has been shown to reduce the size of colon, lung, breast, ovarian, and pancreatic cancer tumors.
“Now is the time to further enhance the power of immunotherapy, and we believe CF33-hNIS has the potential to improve outcomes for our patients in their battle with cancer,” said lead study investigator Daneng Li, an assistant professor of City of Hope’s Department of Medical Oncology & Therapeutics Research, in a statement.
Experience Next-Level Sound
Spatial audio with dynamic head tracking provides theater-like sound that surrounds you
Vaxinia will be tested out in a Phase I trial of 100 cancer patients with metastatic or advanced solid tumors who have tried out at least two other treatments. Groups will either receive Vaxinia alone or in combination with pembrolizumab, an immunotherapy drug.
Phase I trials are explicitly meant to test the safety and optimal dose of an experimental treatment, not to definitively prove that a treatment works. But the researchers will be keeping track of whether patients are appearing to respond to Vaxinia, whether their cancers are progressing, and their survival rate over the next several years—data that will make or break any plans for further clinical research. The trial is expected to be completed by early 2025.
Related: Doctors Used Bacteria-Killing Viruses to Take Down an Incurable Superbug

See also  Breast Cancer and Diabetes Join Forces To Promote Disease - Technology Networks

source

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Fighting cancer requires an open mind – Merck
  • Rain Targets Normal p53 Expression with Possible Pan-Cancer Therapeutic – BioSpace
  • Sarasota Memorial Earns Accreditation for Rectal Cancer Care – SRQ Daily Jun 21, 2022 – SRQ Magazine
  • Community rallies behind 10-year-old with bone cancer – WCAX
  • Black women die of breast cancer at rates nearly 40% higher than white women, local researcher finds in new study – KSAT San Antonio

Recent Comments

  1. IvyBer on Gynecologic Cancer Studies: What to Look for at ASCO 2022 – Medscape
  2. hotshot bald cop on A solution to asbestos waste?
  • Fighting cancer requires an open mind – Merck
  • Rain Targets Normal p53 Expression with Possible Pan-Cancer Therapeutic – BioSpace
  • Sarasota Memorial Earns Accreditation for Rectal Cancer Care – SRQ Daily Jun 21, 2022 – SRQ Magazine
  • Community rallies behind 10-year-old with bone cancer – WCAX
  • Black women die of breast cancer at rates nearly 40% higher than white women, local researcher finds in new study – KSAT San Antonio
  • Asbestosis Treatmeant
  • asbestosiscancer news
  • Tipes of Cancer
  • Treatment

Info

  • Aviso Legal
  • Contact
  • Personalizar Cookies
  • Política de Cookies
  • Política de Privacidad
  • DMCA
  • Terms and Conditions
  • Fighting cancer requires an open mind – Merck
  • Rain Targets Normal p53 Expression with Possible Pan-Cancer Therapeutic – BioSpace
  • Sarasota Memorial Earns Accreditation for Rectal Cancer Care – SRQ Daily Jun 21, 2022 – SRQ Magazine
  • Community rallies behind 10-year-old with bone cancer – WCAX
  • Black women die of breast cancer at rates nearly 40% higher than white women, local researcher finds in new study – KSAT San Antonio

Signs of AsbestosASBESTOSIS CANCER CENTER

➡️ Signs of Asbestos the results of semipermanent exposure to amphibole don’t seem till ten to forty years when initial exposure to asbestos. Signs and symptoms of asbestosis might include:

Asbestos Cancer MesotheliomaASBESTOSIS CANCER CENTER

➡️ Asbestos Cancer Mesothelioma carcinoma treatment at King Hussein Cancer Center A treatment arrange is developed supported the scale of the neoplasm and therefore the stage of the disease. The treatment plan could embody surgery, radiation therapy and chemotherapy.

©2022 | Built using WordPress and Responsive Blogily theme by Superb
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT